FDA Approved: LAMISIL AT — Supplemental Application (Karo Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for LAMISIL AT (terbinafine hydrochloride) from Karo Healthcare Inc. under NDA 021124. This action updates/expands the e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Corporis
• Tinea Cruris
• Tinea Pedis
• Tinea Versicolor

Drugs mentioned

• LAMISIL AT (TERBINAFINE HYDROCHLORIDE)

Snippet

SUPPL AP for LAMISIL AT (TERBINAFINE HYDROCHLORIDE)